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H-2  RESTRICTION  OF  VIRUS-SPECIFIC  CYTOTOXICITY 
ACROSS  THE  H-2  BARRIER 
Separate  Effector T-Cell  Specificities Are Associated with 
Self-H-2 and  with the Tolerated  Allogeneic  H-2 in Chimeras* 
BY ROLF M.  ZINKERNAGEL 
(From the Department of Immunopathology,  Scripps Clinic and Research Foundation, La Jolla, 
California 92037) 
Increasing  experimental  evidence  suggests  that  most  if not  all  T-cell-me- 
diated immune functions in mice are dependent on structures coded in the major 
histocompatibility (H-2) complex. To express an IgG immune response to solu- 
ble, chemically inert,  noninfectious antigens,  T-helper cells from conventional 
mice and precursors of antibody-forming B cells must share the I  region of H-2 
(1-5).  Similarly,  the specificity of murine T cells which are sensitized to infec- 
tious agents, chemically reactive antigens,  or to alloantigens is determined by 
cell surface self-structures coded in the K  and D  regions of H-2  (6-10, reviewed 
in 11-13). The antigen recognized by T cells has been postulated to be "altered 
self", i.e.,  altered major transplantation  antigens or structures that are coded 
very closely to them (altered self hypothesis). An alternative explanation is the 
dual recognition model. It suggests that T cells interact dually with other cells 
via  an  immunologically  specific receptor  for antigen  and  structures  for  self- 
recognition (reviewed in 3,  11,  12,  14). 
The rule that H-2 compatibility is required between T cells and the cells with 
which  they  interact  is  apparently  not  absolute.  T  cells  from  zygote  fusion 
chimeras  (tetraparental  mice, 15) or from irradiated F1 bone marrow chimeras 
(16) can cooperate with bone marrow-derived lymphocytes (B cells) of syngeneic 
and  the  tolerated  allogeneic  haplotypes.  Similarly,  virus-immune  or  TNP- 
immune  cytotoxic T  cells from  irradiated  F1 bone marrow  chimeras  can  lyse 
infected targets of both syngeneic and tolerized allogeneic, but not of unrelated, 
H-2 haplotypes (17-19). This finding has been used extensively in discussing the 
nature  of the H-2  restriction.  At  first  glance  these  results  suggest  that  the 
specificity of T  cells is for the viral antigen  alone and favor the physiological 
interaction model (3). However, this interpretation  depends on the assumption 
that the same cytotoxic T  cell can kill infected syngeneic as well as tolerated 
allogeneic targets.  Therefore,  it seems crucial to determine,  first, whether the 
crossing  of the  H-2  barrier  by H-2-tolerant  virus-immune  cytotoxic  T  cells 
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reflects the absence of allogeneic inhibition or suppression, or second, whether 
under tolerance conditions separate T cells of one H-2 type are generated which 
are differentially associated with either the syngeneic or the tolerated allogeneic 
H-2 haplotype. To distinguish between these two possibilities, the specificity of 
virus immune T cells from irradiation bone marrow chimeras was investigated. 
The results from using cold unlabeled targets for competitive inhibition of virus- 
specific 51Cr release in cytotoxicity assays in vitro and from selective secondary 
restimulation  experiments  in mixed lymphocyte cultures  (MLC)  1 support the 
second possibility. Thus, virus-specific cytotoxicity across the H-2 barrier is also 
H-2 restricted. 
Materials  and Methods 
Mice.  C3H,  DBA/2, B10.BR,  B10.D2,  C57BL/6,  C3H  ×  DBA/2 Fj  were purchased from The 
Jackson Laboratory, Bar Harbor, Maine. B10.BR × B10.D2 F~ were bred at the Scripps Clinic and 
Research Foundation. Chimeras were produced according to the method of yon Boehmer et al. (16). 
C3H  x  DBA/2 were irradiated with 900 rads, B10.BR ×  B10.D2 F~ with 950 rads. 24 h later these 
mice were transfused with a  total of 2  x  107 AKR anti-O C3H  +  complement (C')-treated bone 
marrow cells. Mice were reconstituted either with bone marrow cells from one parent alone or with 
equal amounts of cells from both parents. Their drinking water was supplemented with antibiotics 
for 2  wk.  Of about 70 chimeras,  80%  survived and 20% died during the first 10-12  days after 
reconstitution. 
Virus.  The WE strain of lymphocytic choriomeningitis virus (LCMV) and the WR strain of 
vaccinia  virus  (a  gift  from  Dr.  W.  K.  Joklik,  Duke  University,  Durham,  N.  C.)  have  been 
described (20-22). Mice were immunized with 5 ×  102 plaque-forming units (PFU) of LCMV or 1 x 
107 of vaccinia virus, and spleens were harvested 7 and 6 days later, respectively. 
Cell Lines.  The  cell  lines used  have  been  described  previously  (18,  20).  The  persistently 
LCMV-infected L929 cells were originally obtained from Dr. M. B. A. Oldstone, Scripps Clinic and 
Research Foundation. 
Antisera.  Anti-H-2 sera were produced by hyperimmunizing B10.BR mice with B10.D2 spleen 
cells and vice versa.  Incubation of appropriate target cells at 5  x  107/ml with 1:2-1:30 diluted 
antisera (30 min, 4°C) and with a selected unabsorbed rabbit C' (1:6, 30 min, 37°C) lysed >97% of 
the relevant spleen cells, but did not lyse syngeneic or unrelated spleen cells (18). AKR anti-8 C3H 
was from Bionetics, Kensington, Md., (cat. 8301-01, lot no. 231-61-5),  used at 1:10 (30 min, 4°C) and 
with rabbit C'  (1:6,  30 min, 37°C)  it lysed 42% of the spleen cells specifically. 
MLC In Vitro and 5xCr Release Assay.  Primary alloreactive cytotoxic T cells were generated in 
vitro as described by Lafferty et al.  (23).  Secondary in vitro MLC were performed according to 
Plata et al. and Dunlop and Blanden (24, 25).  Minimal essential medium supplemented with 10% 
heat4nactivated fetal calf serum, nonessential amino acids, and antibiotics (complete medium) 
(Flow Research  Laboratories,  Rockville,  Md.)  was used with 3  x  10 -5  M  ~-2-mercaptoethanol 
(Sigma Chemical Co., St. Louis, Mo.). The 5~Cr release assays and the methods used for competi- 
tive inhibition with unlabeled cold targets have been described in detail (7, 26). 
Results 
Characterization of Chimeras.  The following criteria indicated that lympho- 
reticular chimerism was completely established in the irradiated bone marrow 
reconstituted chimeras. At sacrifice, none of the normal or infected mice showed 
macroscopic signs of ongoing graft versus host disease. Lymphocytes from Pj 
F1,  P2  --*  F1,  and  P1  +  P2 -*  F1  chimeras  were  able,  in  MLCs,  to  generate 
cytotoxicity against an unrelated third H-2 haplotype but not against either of 
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the parental  (P) H-2 types. Thus, chimeric lymphocytes were specifically unre- 
sponsive to the  tolerizing H-2  haplotype  (Table I).  Reconstitution of the  chi- 
meras was complete in all cases tested,  since the anti-H-2 k and H-2  d antisera 
plus C' treatments caused lysis of virtually all spleen cells from C3H --~ C3H x 
DBA/2 F, and from DBA/2 -~ C3H x  DBA/2 F, cells, respectively. The unrelated 
anti-H-2  serum did not cause significant  lysis.  The tetraparental  F, chimeric 
spleen cells were all lysed by anti-H-2  d  +  anti-H-2 k antisera  combined;  each 
alone lysed about 50% of the cells (Tables II and III). 
Virus-Specific Cytotoxic T  Cells From Chimeras Lyse Across the H-2 Bar- 
rier.  Vaccinia-virus immune spleen cells of one parental haplotype from all P, 
(H-2  k) ---> F, (H-2 k×~) or P2 (H-2 ~) --~ F, (H-2 k×d) chimeras lysed syngeneic and 
tolerated parental  allogeneic virus-infected target cells but not uninfected tar- 
gets or the unrelated third party infected target cells of H-2  b type (Table II, Exp. 
1). This activity was anti-0-sensitive (Table II, Exp. 2). Exactly the same results 
were obtained with F, chimeras that had been reconstituted with 14-16-day-old 
fetal liver cells of one parental H-2 type (data not shown). 
Tetraparental  F, bone marrow chimeras (P, + P2 --~ F1) infected with vaccinia 
virus or LCMV generated anti-0-sensitive cytotoxic T cells of both parental H-2 
types, and each of these T-cell types lysed both infected parental type targets but 
not normal targets or cells of unrelated H-2 types (Table II, Exp. 3; Table III). 
Specificity of Chimeric  T  Cells.  The  specificity of chimeric  virus-immune 
effector T  cells was first determined by competitive inhibition  experiments  in 
vitro.  5'Cr release  from  infected  syngeneic H-2 k or tolerated  allogeneic H-2 d 
targets caused by LCMV-immune cytotoxic T cells from C3H (H-2 k) --* C3H × 
DBA/2 F, (H-2 k×~) could be inhibited competitively only with unlabeled infected 
targets that were H-2 compatible with the labeled target. Thus, unlabeled cold 
LCMV-L cells inhibited 5~Cr release from LCMV-L 929 cells by C3H --~ C3H  x 
DBA/2 F, immune spleen cells completely, but had little effect on lysis of labeled 
LCMV-J774.  Cold LCMV-J774 had little effect on lysis of labeled LCMV-L929 
cells, however, competed with labeled LCMV-J774 to about 70% (Table IV, Exp. 
1). With higher ratios of infected competitor cells added (6:1),  the inhibition  of 
~'Cr release was even more evident (Table IV, Exp. 2). These results indicate the 
presence in these chimeras of at least two (probably four) sets of T-cell specifici- 
ties associated with either the syngeneic or the tolerated allogeneic H-2  type. 
Only cold targets,  which were compatible with both immune spleen cells and 
labeled  targets,  competed  similarly  in  the  specific lysis by C3H  or  BALB/c 
LCMV-immune  spleen  cells  (Table  IV,  Exp.  1).  These  inhibitions  were less 
pronounced  than  for the  chimeras  because the cytotoxic activity was greater 
than  that  of the  chimeras.  Therefore  competition  by threefold excess of cold 
targets was not sufficient to inhibit 5'Cr release by more than 40-45%. 
Further evidence for the presence of at least two separate T-cell specificities in 
chimeras that lysed either the syngeneic or alternatively the tolerated alloge- 
neic-infected target cells, but not both, was obtained from secondary restimula- 
tion of memory T cells in vitro (Table V). LCMV-immune spleen cells from C3H 
--~ C3H  x  DBA/2 F, mice, which were infected 4-wk previously, were restimu- 
lated in vitro with infected macrophages from the syngeneic (H-2 k) or infected 
J774 cells of the allogeneic (H-2  ~) parents at a ratio of 8:1 for 4 days. Cytotoxic 
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TABLE  I 
Chimeric*  Lymphocytes'  Capacity to Generate Alloreactive  Cytotoxicity  in MLC$ 
Percent ~Cr release from target cells at lym- 
phocyte to target ratios§ 
Responder lymph node cells (H-2  Stimulator 
haplotype)  spleen cells  EL4 (b)  L929  (k)  P815  (d) 
1.5  0.3  1.5  0.3  1.5  0.3 
C57BL/6 (b)  C57BL/6  1911  19  12  10  11  10 
C3H  20  20  96¶  27  14  12 
BALB/c  24  19  24  15  10111  29 
DBA/2 -* C3H  ×  DBA/2 F~  C57BL/6  98¶  31  13  11  12  12 
(d)  (k  x  d)  C3H  29  21  15  12  13  11 
BALB/c  29  21  14  12  11  11 
C3H --* C3H  x  DBA/2 F1  C57BL/6  102¶  30  13  11  22  12 
(k)  (k  x  d)  C3H  27  21  18  12  18  14 
BALB/c  26  23  18  15  20  13 
C3H +  DBA/2 --* C3H  x  DBA/2 FI  C57BL/6  105¶  32  14  15  23  13 
(k)  (d)  (k  x  d)  C3H  28  21  17  15  21  13 
BALB/6  27  23  16  15  22  14 
* C3H x  DBA/2 FI mice were irradiated with 900 rads and 1 day later reconstituted with 2 x  107 
viable anti-0-treated bone marrow cells of  one or of  both parents. Mice were sacrificed 2 mo later, 
and mesenteric lymph nodes were used in MLC. 
MLC were done as described by Lafferty et al.  (23).  2  x  106 responders and 4  x  l0  s 850 rads 
irradiated stimulator cells were cultured for 5 days in 24 flat-bottomed well tissue culture plates 
(Linbro Chemical Co., New Haven, Conn.) with 3  x  10 -5 M fl-2-mercaptoethanol in complete 
medium. 
§ ~Cr release assays used 5  x  104 target cells/weI1 mixed with 7.5 x  104 or 1.5  x  104 viable cells 
from MLC. 
iI Means from triplicates. SEM were 0.5-1.3% for EL4, 0.7 to 2.0% for L929, and 0.6 to 2.0% for P815. 
¶ Significantly greater than other values (P <  0.001). 
H-2  compatible with the infected stimulator cells.  Uninfected stimulator cells 
did not cause generation of great cytotoxicity (Table V). 
Discussion 
These results demonstrate, one, that vaccinia virus or LCMV-infected tetra- 
parental P1 + P2 --* F1 chimeras generate T cells of one or the other parental H-2 
haplotype, and each set of these T cells can lyse across the H-2 barrier infected 
target cells of  the other tolerated parental H-2 type. Two, virus-infected irradia- 
tion bone marrow chimeras generate cytotoxic T cells of one parental H-2 type 
and  of at  least  two  separable H-2-restricted  specificities; one  is  specific  for 
infected syngeneic targets, the other for infected tolerated parental allogeneic 
target cells of  the tolerated parental H-2 specificity. Third, virus immune T cells 
from chimeras are not lytic against infected target cells of an unrelated H-2 
type. 
Therefore, one can conclude first, that the requirement to recognize H-2  is 
unidirectional in that only the T cells must recognize the same altered H-2 to 
which they have been sensitized. This conclusion is supported by the evidence ROLF  M.  ZINKERNAGEL  937 
TABLE II 
Vaccinia Virus-Specific Cytotoxic Activity in Spleens From F, Irradiation Chimeras* 
Percent '~'Cr  release from target cells§ 
Immune spleen cell do-  Antiserum treatment +  L929 (h)  P815 (d)  C57BL]6 (b) 
nora (H-2  haplotype)  C'  (% lysed)$ 
Unin.  Unin-  Vacci-  Unin- 
Vaccinia  Vaccinia  fected  fected  nia  fected 
Experiment 1 
DBA/2 (d) 
C3H x  DBA/2 F, 
(k  ×  d) 
C3H (k) 
C3H x DBA/2 F 
(k  x d) 
C3H (k) 
Normal C3H 
BALB/c (d) 
Normal BALB/c 
C57BL/6 (b) 
Medium 
Experiment 2 
C3H (h) 
C3H x  DBA/2 F, 
(h  ×  d) 
Normal C3H 
C3D2 F, 
Experiment 3 
B10.BR (k)  +  B10.D2 (d) 
B10.BR x  B10.D2 F, 
(h  x  d) 
C57BL/6 (b) 
None  (11)  41~1  16  83¶  20  34  35 
Anti-H-2  k  (13)  44¶**  -  $*  82¶**  -  - 
Anti*H-2  ~  ( > 95)  20  -  20  -  - 
None  (20)  565  15  81¶  21  36  38 
Anti-H-2  k  (>98)  25  -  23  -  -  - 
Anti-H-2  ~  (2I)  52¶**  -  78¶**  -  -  - 
None  (16)  71  17  21  20  36  37 
Anti-H-2  k  (>97)  28  ..... 
Anti-H-T  (17)  66¶**  .... 
15  -  -  -  33  36 
None  (12)  13  15  81¶  18  37  38 
Anti-H-2  ~  (13)  -  -  84¶**  -  -  - 
Anti-H-2  ~  (>95)  -  --  14  -  -- 
14  16  13  15  35  37 
17  18  16  18  84¶  35 
13  15  13  15  37  39 
None  (15)  76¶  28  92¶  37 
Anti-H-2  ~  (>95)  27  -  35 
Anti-H-2  ~  (17)  70~**  -  90~**  - 
AKR-anti.0  (54)  27  -  37  - 
C3H 
Normal AKR  (17)  74¶**  -  90~  - 
serun~ 
25  26  35  35 
None  (14)  86¶  42  72¶  28  31  32 
Anti-H-T  + 
anti-H-2"  (>96)  43  42  23  29  -  - 
Anti-H-2  k  (52)  64¶  41  46¶  29  -  - 
Anti-H-2  d  (60)  70~  42  45¶  28  -  - 
None  44  43  27  30  91¶  34 
*  F  1 chimeras were used 4-10 wk after reconstitution. Mice were infected i.v. with 1 x  107 PFU of WR vaccinia virus and sacrificed 6 days 
later. 
* Single cell suspensions of spleen cells (5 ×  10'/ml) in minimal essential medium were incubated with anti-H-2 sera at a  1:2 final dilution 
with anti-8 sera of a  1:I0 final dilution for 30 rain at 4°C. Rabbit C' was added at a  1:8 final dilution for 30 rain at 37°C. Cell viability was 
determined by trypan blue exclusion. Cells were washed and resuspended according to their viability before antiserum treatment and 
as~yed  at 30 total spleen cells to 1 target cell. 
§ S'Cr release assay was performed as described. Incubation time was: Experiment 1, 6 h  at 37°C; Experiment 2, 7 h; Experiment 3, 12 h. 
II  Means of triplicate~. SEM were 0.6 to 2.2 for L929, 1.O to 2.5 for P815, and 0.6 to 2.5 for C57BL/6 macrephages. 
¶  Statistically significantly greater than normal spleen cell controls (P <  0.Ol). 
** Not different from untreated control. 
*~  -,  not tested. 
that anti-H-2 sera directed against K- and D-region products of the target cell 
alone can inhibit lysis (27, 28), and that target cells which do not expressH-2 but 
are infected with virus are not lysed by T cells (R. M. Zinkernagel and M. B. A. 
Oldstone,  unpublished).  Second,  it is not the simple lack of allogeneic or other 
suppressive  effects by allogeneic  target  or spleen  cells  which does not permit 938  H-2  RESTRICTION  OF  CYTOTOXICITY  ACROSS  H-2  BARRIER 
TABLE  III 
LCMV-Specific Cytotoxic Activity in Spleens From Tetraparental F~ Irradiation 
Chimeras* 
Percent '~'Cr release from target cells§ 
Immune spleen cell do-  Antiserum treatments  L929 (k)  J774  (d) 
nors (H-2 haplotype)  +  C' (% lysed) 
LCMV  Unin-  LCMV  Unin- 
fected  fected 
C3H (k)  +  DBA/2 (d) --,  None  (21)  471t¶  28  73¶ 
C3H x  DBA/2 F,  Anti-H-2  k  (69)  42¶  -**  67¶ 
(k  x d)  Anti-H-2  ~  (66)  44¶  -  69¶ 
AKR anti-0  (60)  29  -  33 
C3H 
Normal AKR  45¶  -  67¶ 
serum 
37 
C3H x  DBA/2 F,  None  (13)  50¶  -  87¶  38 
(k  x d)  Anti-H-2  k  (>96)  28  -  38  - 
Anti-H-2  d  (>96)  27  -  37  - 
Anti-H-2  '~  (15)  48¶  -  80¶  - 
AKR anti-0  (62)  27  -  38  - 
C3H 
Normal C3 +  D2 --*  None  28  24  36  37 
C3H x  DBA/2 F, 
Normal C3H  × DBA/2 F,  None  28  25  35  36 
Medium  30  24  33  34 
* One chimera (10 wk) was infected i.v. with 5 x  105 PFU of WE LCMV and sacrificed 7 days 
later. 
$ Single cell suspensions in minimal essential medium (5 x 10Uml) were treated with antisera as 
in Table II. 
§ ~lCr release assay was done at a viable lymphocyte to target ratio of 30:1 for 12 h at 37°C. 
II  Means of triplicates. SEM were 1.1 to 2.0 for L929 and 1.4 to 2.9 for J774. 
¶ Significantly greater than controls, P  <  0.01. 
**  -,  not tested. 
lysis of infected targets of the tolerized H-2  type across the H-2  barrier.  Third, 
the H-2 restriction is in fact absolute since the virus-immune  chimeric cytotoxic 
T  cells that can cross the Ho2 barrier cannot lyse syngeneic infected target cells 
or vice versa. 
The H-2  restriction phenomenon  thus does not result from a  requirement  for 
compatibility at H-2K  or D, but reflects the specificity of any cytotoxic T  cells for 
viral antigen  to  which  they  have  been  sensitized  (10,  11)  and  for  any  self or 
tolerated  K-  or  D-coded  cell  surface  structure.  Virus-immune  T  cells  from 
conventional H-2 k  mice  can  only lyse  infected H-2 k  target  cells because  they 
have been sensitized exclusively against virus-associated H-2 k  and have never 
encountered viral antigen  associated  with H-2 '~  or H-2 b.  In H-2 k  ~  H-2 k×'~ F1 
chimeric mice H-2 ~ lymphocytes accept H-2 k as well as H-2" as ~normal" self cell 
surface  markers.  During  infection they  are  thus  exposed to,  and  distinct  and 
separate T  cells are sensitized to,  viral antigen associated with H-2 k  and viral ROLF  M.  ZINKERNAGEL  939 
TABLE  IV 
Separate Sets of T Cells of One H-2 Haplotype From F1 Bone Marrow Chimeras Are 
Specific for Altered Self H-2 and For Altered Alloantigen Demonstrated  by Cold 
Target Competition Experiments In Vitro 
Percent ~lCr release from 
Unlabeled$ LCMV- 
Immune  spleen*  Antiserum*  infected competitor  LCMV-target cells§ 
cells (H-2 haplo-  +  C' treat-  target cells (H-2 
type)  ment  C57BL/6 
haplotype)  L929 (k)  J744 (d)  (b) 
Experiment  1 
C3H  (k) --,  C' control  None  4211¶  78¶  -~ 
C3H  ×  DBA/2 F~  Anti-H-2  k  None  28  43  - 
(k  ×  d)  Anti-H-2  d  None  40¶  72¶  - 
None  None  45¶  82¶  34 
None  3  ×  LCMV-J774  (d)  43¶  52¶**  - 
None  3  ×  LCMV-L929 (k)  28**  80¶  - 
BALB/c (d)  None  None  29  76¶  36 
3  x  LCMV-J774  (d)  -  61¶**  - 
3  ×  LCMV-L929 (k)  -  74¶  - 
Anti-H-2  k  None  -  77¶  - 
Anti-H-2  d  None  -  41  - 
C3H(k)  None  None  79¶  44  33 
3  ×  LCMV-J774  (d)  71¶  -  - 
3  ×  LCMV-L929 (k)  "'1"*  -  - 
Anti-H-2  k  None  ov  -  - 
Anti-H-2  d  None  78¶  -  - 
Normal C3H  28  39  34 
C57BL/6 (b)  None  None  32  45  85¶ 
Experiment 2 
C3H  (k) --,  C' control  None  57¶  56¶  - 
C3H  ×  DBA/2 F1  Anti-H-2  k  None  35  19  - 
(k  ×  d)  Anti-H-2  d  None  56¶  54¶  - 
None  None  58¶  57¶  42 
None  6  ×  LCMV-J774  (d)  54¶  20**  - 
None  6  ×  LCMV-L929 (k)  38**  55¶  - 
C57BL/10 (b)  44  25  76¶ 
* Mice  were  infected  i.v.  with  5  ×  102  PFU  of WE  LCMV  and  sacrificed  7  days  later.  For 
antiserum treatment  see Tables II and HI and Materials and Methods. 
$ Cold  target  competition  experiments  were  performed  as  described  originally  by  Ortiz  de 
Landazouri and Herbermann  (26) and as used previously in this system (7). A  threefold excess 
of unlabeled LCMV-infected target cells was added to the labeled monolayers and mixed with 
the added spleen cells. 
§ 51Cr release assays were performed at a  10:1 lymphocyte to target ratio for 12 h  at 37°C. 
II  Means of triplicates.  SEM were  1.1 to 2.5 for L929 cells,  1.5 to 2.7 for J774,  and 1.2 to 2.8 for 
C57BL/6 macrophages. Percent release by immune cells on uninfected target cells were for Exp. 
1:26-29 on L929, 38-43 on J774, 32-36 on C57BL; Exp. 2:35-42 on L929, 20-23 on J774, 38-41 on 
C57BL. C57BL immune cells caused release from normal targets which was not different from 
the release on infected targets. 
¶ Significantly greater than relevant control values (P <  0.05). 
** Significantly smaller than when cold H-2 incompatible LCMV targets were added (P <  0.05). 
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TABLE  V 
Selective Secondary Restimulation In Vitro of  Distinct LCMV-Immune T Cells Specific 
Either For Altered Self or For Altered AUoantigen 
Percent ~'Cr release from 
target cells$ 
LCMV-infected  Spleen cells* restimu-  stimulator cells  L929 (k)  J774 (d)  |ated in vitro  (H-2 haplotype) 
LCMV Unin-  LCMV Unin- 
fected  fected 
C3H -* C3H  × DBA/2 F,  LCMV-immune  C3H M~ (k)  60§11  40  38  31 
(k)  (k  x d)  Normal  C3H M(b (k)  34  34  47  41 
C3H  x  DBA/2 F,  LCMV-immune  C3H M~ (k)  5111  39  50  31 
(k  × d)  Normal  C3H M~b (k)  34  32  48  40 
C3H --* C3H  x  DBA/2 F,  LCMV-immune  J774 (d)  32  34  10111  33 
(k)  (k × d)  Normal  J774 (d)  31  33  48  35 
C3H  x  DBA/2 F,  LCMV-immune  J774 (d)  31  32  8311  32 
(k  × d)  Normal  J774 (d)  31  33  52  38 
Normal C3H  × DBA/2 F,  32  37  34  29 
controls 
Medium  30  34  35  30 
* Spleen cell donors were infected with 5  ×  102 PFU of WE LCMV and sacrificed 4 wk later. 
Immune or normal spleen cells, 4 × 10~/well, were cocultivated with 5 × 105 LCMV-infected cells 
(peritoneal cells or J774 cells infected for 24 h with LCMV) in complete medium containing 3 × 
10 -5 M mercaptoethanol for 4 days at 37°C. 
51Cr release assay was done at a viable lymphocyte to target cell ratio of 10:1 for 12 h at 37°C. 
§ Means of triplicates. SEM were 1.0 to 2.1 for L929 and 1.3 to 2.8 for J774. 
II Significantly greater than on uninfected targets or than normal spleen cell stimulated in vitro 
and assayed on infected targets (P <  0.01). 
antigen  associated  with  H-2 d.  One  can  extrapolate  from  experiments  with 
conventional heterozygote FI and H-2 recombinant  mice (8) that P, (H-2 ~) --* F, 
(H-2 k×d) chimeras  probably  have  four  sets  of  T-cell  specificities,  one  each 
associated with the syngeneic and allogeneic tolerated K  and D  specificities. 
The results presented  here  are compatible with the  idea that  separate  cyto- 
toxic effector cells from chimeras  are specific for altered self and alternatively 
for altered tolerized alloantigen. This interpretation  implies that the H.2K and 
D  structures are not only mandatory  because they may be the sites at which cell 
wall damage  measurable  by 5'Cr release is made easiest, but also because they 
are  an  essential  part  of the  sole  antigenic  entity  seen  by  T  cells expressing 
clonally a  single immunological  receptor (altered self hypothesis). 
Is there another  explanation  for the H-2 restriction of virus-specific cytolysis 
across the H-2 barrier? Does H-2-associated specificity of effector T  cells reflect 
specificity for altered self or, alternatively,  the need for a  dual recognition one 
for viral antigen and one for aK-  or D-coded self-marker (6-11), or is the answer 
somewhere  in  between  these  extremes?  Stated  differently,  is  the  distinction 
made  by the T  cell between  uninfected and infected target  cells a  process that 
involves active recognition of both infected and uninfected cells or recognition ROLF  M.  ZINKERNAGEL  941 
only of infected targets  (29).  A question of general importance,  which unfortu- 
nately cannot yet be answered because all the available data concerns effector T 
cells only, is whether dual or physiological recognition may be essential at the 
T-cell induction level. 
The  apparently  general  H-2  restriction  of virus-immune  T-cell  specificity 
even  for  chimeric  T  cells,  therefore,  could  also  be  explained  with  the  dual 
interaction model. It assumes that T cells recognize normal self (but do not react 
with normal self). Therefore in irradiation  bone-marrow chimeras,  interaction 
structures for the tolerated alloantigens,  as well as self, but not for unrelated 
alloantigens,  differentiate during the regeneration process of the lymphoreticu- 
lar  system  (14).  As  pointed  out  earlier,  the  dual  interaction  model  would 
demand the existence of two separate clonally expressed recognition systems on 
virus-immune cytotoxic T cells, one immunologically specific for viral antigen 
and  one for self recognition  separately for each K  or D  structure  present  (7). 
The evidence presented here and the results from testing conventional F1 and H- 
2  recombinant mice (7) are compatible with this dual recognition model only if 
interaction  structures for self or tolerated alloantigen  are also expressed clon- 
ally  and  on  separate  T  cells  for  each K  or D  structure,  together  with  the 
generally accepted clonally expressed immunologically specific receptors. T cells 
specific for viral antigen which express the physiological interaction  structure 
for tolerated allogeneic H-2K do not express the structures for syngeneic H-2K 
or the syngeneic or allogeneic H-2 self-structures. 
Because of the fact that virus-immune T cells from some of  the mutant mice do 
not lyse infected target cells of wild-type H-2 specificity (20), it is unlikely that 
the physiological interaction structures are coded for by the same genes as the 
H-2K and H-2D loci. Therefore, the appropriate genes would have to be either 
closely linked to these loci or not be located in the K  or D  regions of H-2 or not 
within H-2 at all. This alternative hypothesis is thus a model for T-cell recogni- 
tion involving simultaneously two distinct, clonally expressed receptors that are 
not identical with the now known H-2 gene product and may not be an H-2 gene 
product at all. The cell structure that is recognized is a K- or D-region product 
for cytolytic interaction,  probably an/-region-coded structure for helper T-cell 
interactions.  The frequency of clonal expression of recognition units for antigen 
and for the self-marker would have to differ vastly in that the frequency ofT-cell 
clones expressing self-interaction receptors would be much greater. 
The double clonal,  dual recognition system implies that T-cell-mediated cell 
damage which results in target cell death and 51Cr release is made through the 
H-2K  and H-2D  self-marker.  Therefore  activity against  alloantigens  may be 
explained most simply as follows. Because the K  and D  structures are the sites 
for self-T-cell-mediated  cell wall damage  the recognition  of them by a  single 
immunological receptor is sufficient for lysis. Double recognition is not needed 
because the immunological receptor against alloantigen hits the crucial struc- 
ture directly. In contrast, the self-recognitive structure alone cannot deliver the 
lytic signal in a closed syngeneic system. The self-T cells possessing immunolog- 
ical receptors against self-K orD structures, i.e. self-reactive T cells, must have 
been eliminated constantly, probably in the thymus (29). 
Why has it proven impossible so far to generate virus-immune or TNP-specific 942  H-2  RESTRICTION  OF  CYTOTOXICITY  ACROSS  H-2  BARRIER 
cytotoxic T cells across the H-2 barrier by cocultivating lymph node cells of  H-2 d 
with virus-infected or TNP-modified allogeneic H-2 k lymphoid stimulator cells? 
The interaction of T cells from conventional mice with viral antigens on alloge- 
neic cells is unlikely to trigger measurable T-cell activity for viral antigen on 
the allogeneic cell, first, because activity against alloantigens is more easily 
triggered and therefore supersedes (e.g., because of additional I-region differ- 
ences and because  alloreactivity requires only one  immunologically specific 
interaction without self-interactions) and, second, because the combination of 
interaction structures for alloantigens and recognition structure for virus is rare 
or absent.  This imbalance would change under conditions of tolerance.  Here 
interaction structures for self and tolerated alloantigen could occur with about 
the same frequency. The possibility that the self-recognitive structure and the 
immunological receptor recognizing this K  or D  structure as alloantigen are 
probably  identical  has  been  discussed  elsewhere  (30).  The  question  is  open 
whether these two clonally expressed recognition units  are combined in one 
receptor comprising two chains, which recognize a  complex between self plus 
viral antigen, or whether the two receptors are separate entities.  The second 
possibility seems less likely. Since multiple self-recognition alone or multiple 
recognition of viral antigen alone is of much lesser avidity than when both are 
recognized simultaneously, it is probable that the two receptors of a dual recog- 
nition  system would have to  be linked somehow.  Such a  composite receptor 
model is functionally not distinguishable from the altered self model. 
Some of these possibilities have been discussed previously but were at that 
time regarded as a  less likely explanation for the H-2 restriction phenomenon 
than the altered self hypothesis (8,  10,  11,  20). However, the modified double 
clonal dual recognition model is a  viable alternative which fits the available 
data well, particularly the results with the H-2  mutants and chimeras in the 
virus models and probably explains better the evidence from minor histocompat- 
ibility antigen (31) and H-Y antigen (32) system, alloreactivity, and the recent 
observation that  the idiotypic specificity of T-cell receptor and  antibodies  is 
similar or identical for a given antigen (33-36). 
The reformulated dual recognition model stresses the fact that self-recognitive 
structure for one H-2K or H-2D product and immunological receptor for viral 
antigen  are  linked  but  independently,  clonally expressed  on  virus-immune 
cytotoxic T cells. Furthermore, as appears probable from these chimera experi- 
ments and experiments with the H-2 mutants, and as we have discussed else- 
where, it seems likely that the gene (probably emerging by somatic mutation) 
coding for the self-recognitive structure for e.g.  self-K  k is  identical with the 
immunological receptor against alloantigen K k. 
Only the biochemical and immunochemical characterization of both the self- 
recognitive and the immunological T-cell receptor(s) or receptor parts or alter- 
natively of the antigens recognized by it/them will confirm or disprove one or the 
other of the hypotheses. 
Summary 
During  infection  with  lymphocytic choriomeningitis or  vaccinia  virus,  F1 
irradiation chimeras reconstituted with bone marrow cells from or both parents ROLF  M.  ZINKERNAGEL  943 
generate cytotoxic T cells which can lyse infected targets across the H.2 barrier. 
However, activity of chimera T cells is H-2  restricted as shown by cold target 
competition experiments and selective restimulation of a  secondary response in 
vitro; T cells of  H-2 k specificity which lyse tolerated infected H-2 d target cells do 
not lyse infected H-2 k or unrelated target cells and vice versa.  Therefore, H-2 
restriction of virus-specific cytotoxic T  cells probably does not reflect need for 
like-like self-interactions for lysis to occur. 
The specificity of virus immune T cells is thus determined by the H-2K and H- 
2D  specificities present  in the infected animal  and which are probably recog- 
nized unidirectionally by T cells. The results are compatible with the idea that T 
cells are specific for "altered self" or "altered alloantigen," i.e., a complex of cell 
surface marker and viral antigen. Alternatively, explained with a dual recogni- 
tion model, T cells may possess two independently, clonally expressed receptors, 
a  self-recognizer which is expressed for one of the syngeneic or tolerated alloge- 
neic K  or D  "self" markers,  and an immunologically specific receptor for viral 
antigen. 
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